STOCK TITAN

Medpace shareholder Troendle sells shares, holds 19.1%

A September 24 sale entry lists 11,902 MEDP shares at a weighted-average price of $620.23 per share.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Medpace Holdings, Inc. (MEDP) common stock was sold by reporting person August J. Troendle in open-market transactions pursuant to limit orders from August 10 through September 25, 2026. Troendle reported beneficial ownership of 5,396,508 shares (19.1%); Medpace Investors, LLC separately reported 4,733,019 shares (16.8%). Individual entries include a September 22, 2026, sale of 13,059 shares at a weighted-average price of $630.36 per share.

Troendle beneficial ownership 5,396,508 shares Reported amount; 19.1% of the class
Troendle ownership percentage 19.1% Of the class
Medpace Investors beneficial ownership 4,733,019 shares Reported amount; 16.8% of the class
Medpace Investors ownership percentage 16.8% Of the class
September 22 sale 13,059 shares at a weighted-average price of $630.36 per share August J. Troendle reported sale
September 24 sale 11,902 shares at a weighted-average price of $620.23 per share August J. Troendle reported sale
beneficially owned regulatory
"Aggregate amount beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power regulatory
"Shared Voting Power 4,733,019.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 4,733,019.00"
limit orders financial
"executed pursuant to limit orders"
A limit order is an instruction to buy or sell a stock only at a specific price or better — for example, buy only if the price falls to $10 or sell only if it rises to $15. It lets investors control the exact price they are willing to trade, like setting a price request at a yard sale, but it also means the trade may not happen if the market never reaches that price, which affects timing and risk.
weighted-average price financial
"a weighted-average price of $630.36 per share"
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MEDP shares does August J. Troendle report beneficially owning?

August J. Troendle reported beneficial ownership of 5,396,508 shares, or 19.1% of the class. Medpace Investors, LLC separately reported beneficial ownership of 4,733,019 shares, or 16.8%.

How did August J. Troendle execute MEDP stock sales?

Troendle reported open-market sales pursuant to limit orders from August 10, 2026, through September 25, 2026.

What voting and dispositive power did Medpace Investors, LLC report over MEDP shares?

Medpace Investors, LLC reported shared voting power and shared dispositive power over 4,733,019 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





58506Q109

(CUSIP Number)
August J. Troendle
5375 Medpace Way,
Cincinnati, OH, 45227
(513) 579-9911

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
09/24/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D




Comment for Type of Reporting Person:
(Limited liability company)


SCHEDULE 13D


August J. Troendle
Signature:/s/ August J. Troendle
Name/Title:August J. Troendle
Date:09/28/2026
Medpace Investors, LLC
Signature:/s/ August J. Troendle
Name/Title:August J. Troendle/Sole Manager
Date:09/28/2026

Keep reading